The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study
Open accessAbstract
INTRODUCTION: Inadequate initial treatment and delayed hemodynamic stabilization (HDS) may be associated with increased risk of death in severe sepsis patients. METHODS: In order to compare the hemodynamic efficacy and safety of 6% HES 130/0.4 and NaCl 0.9% for HDS in patients with severe sepsis, we designed a prospective, multicenter, active-controlled, double-blind, randomized study in intensive care units. RESULTS: 174 out of 196 patients reached HDS (88 and 86 patients for HES and NaCl, respectively). Significantly less HES was used to reach HDS vs. NaCl (1,379 ± 886 ml in the HES group and 1,709 ± 1,164 ml in the NaCl group (mean difference = -331 ± 1,033, 95% CI -640 to -21, P = 0.0185). Time to reach HDS was 11.8 10.1 hours vs. 14.3 ± 11.1 hours for HES and NaCl, respectively. Total quantity of study drug infused over four consecutive days, ICU and hospital LOS, and area under the curve of SOFA score were comparable. Acute renal failure occurred in 24 (24.5%) and 19 (20%) patients for HES and NaCl, respectively (P = 0.454). There was no difference between AKIN and RIFLE criteria among groups and no difference in mortality, coagulation, or pruritus up to 90 days after treatment initiation. CONCLUSION: Significantly less volume was required to achieve HDS for HES vs. NaCl in the initial phase of fluid resuscitation in severe sepsis patients without any difference for adverse events in both groups. CLINICALTRIALSGOV: NCT00464204.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394
Predicting Fluid Responsiveness in ICU Patients
Michard, F., & Teboul, J.-L. (2002) · Chest · doi:10.1378/chest.121.6.2000 · Cited by 1,367
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde-Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1738-3 · Cited by 868
Schortgen, F., Lacherade, J.-C., Bruneel, F., Cattaneo, I., Hemery, F., Lemaire, F., & Brochard, L. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04211-2 · Cited by 741
A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients
Bagshaw, S. M., George, C., Bellomo, R., & Committe, F. T. A. D. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn009 · Cited by 548
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Perner, A., Haase, N., Guttormsen, A. B., Tenhunen, J., Klemenzson, G., Åneman, A., Madsen, K. R., Møller, M. H., Elkjær, J. M., Poulsen, L. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204242 · Cited by 1,813
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
Myburgh, J. A., Finfer, S., Bellomo, R., Billot, L., Cass, A., Gattas, D., Glass, P., Lipman, J., Liu, B., McArthur, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209759 · Cited by 1,687
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Colloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., Roberts, I., & Ker, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub6 · Cited by 1,115
Zarychanski, R., Abou-Setta, A. M., Turgeon, A. F., Houston, B. L., McIntyre, L., Marshall, J. C., & Fergusson, D. A. (2013) · JAMA · doi:10.1001/jama.2013.430 · Cited by 649
Malbrain, M. L. N. G., Van Regenmortel, N., Saugel, B., De Tavernier, B., Van Gaal, P.-J., Joannes-Boyau, O., Teboul, J.-L., Rice, T. W., Mythen, M., & Monnet, X. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0402-x · Cited by 632
Myburgh, J. A., & Mythen, M. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208627 · Cited by 631
Fluid management for the prevention and attenuation of acute kidney injury
Prowle, J. R., Kirwan, C. J., & Bellomo, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.232 · Cited by 341
Chappell, D., Bruegger, D., Potzel, J., Jacob, M., Brettner, F., Vogeser, M., Conzen, P., Becker, B. F., & Rehm, M. (2014) · Critical Care · doi:10.1186/s13054-014-0538-5 · Cited by 336
Malbrain, M. L. N. G., Langer, T., Annane, D., Gattinoni, L., Elbers, P., Hahn, R. G., De laet, I., Minini, A., Wong, A., Ince, C., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00679-3 · Cited by 323
Colloids versus crystalloids for fluid resuscitation in critically ill people
Lewis, S. R., Pritchard, M. W., Evans, D. J., Butler, A. R., Alderson, P., Smith, A. F., & Roberts, I. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub7 · Cited by 315
Haase, N., Perner, A., Hennings, L. I., Siegemund, M., Lauridsen, B., Wetterslev, M., & Wetterslev, J. (2013) · BMJ · doi:10.1136/bmj.f839 · Cited by 310
Fluid Resuscitation in Sepsis: A Systematic Review and Network Meta-analysis
Rochwerg, B., Alhazzani, W., Sindi, A., Heels-Ansdell, D., Thabane, L., Fox-Robichaud, A., Mbuagbaw, L., Szczeklik, W., Alshamsi, F., Altayyar, S., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0178 · Cited by 309
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
Dart, A. B., Mutter, T. C., Ruth, C. A., & Taback, S. P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007594.pub2 · Cited by 290
Martin, G. S., & Bassett, P. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.11.031 · Cited by 141
for the FISSH Group (Fluids in Sepsis and Septic Shock), Rochwerg, B., Alhazzani, W., Gibson, A., Ribic, C. M., Sindi, A., Heels-Ansdell, D., Thabane, L., Fox-Robichaud, A., Mbuagbaw, L., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3794-1 · Cited by 106
Peeters, Y., Vandervelden, S., Wise, R., & Malbrain, M. L. N. G. (2015) · Anestezjologia Intensywna Terapia · doi:10.5603/ait.a2015.0063 · Cited by 33
Metadata
- Authors
- Guidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J., Maizel, J., Forceville, X., Feissel, M., Hasselmann, M., Heininger, A., & Van Aken, H.
- Venue
- Critical Care
- Published
- 2012
- Volume
- 16
- Issue
- 3
- Pages
- R94
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2116065793
- Cited by
- 344
- References
- 23
- FWCI
- 38.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.